PortfoliosLab logoPortfoliosLab logo
COP vs. EDIT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

COP vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ConocoPhillips Company (COP) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, COP achieves a 26.87% return, which is significantly higher than EDIT's 21.95% return. Over the past 10 years, COP has outperformed EDIT with an annualized return of 13.66%, while EDIT has yielded a comparatively lower -22.22% annualized return.


COP

1D
1.40%
1M
-4.44%
YTD
26.87%
6M
24.31%
1Y
24.65%
3Y*
7.68%
5Y*
18.49%
10Y*
13.66%

EDIT

1D
2.46%
1M
-4.58%
YTD
21.95%
6M
-1.19%
1Y
26.90%
3Y*
-39.82%
5Y*
-41.79%
10Y*
-22.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

COP vs. EDIT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
COP
ConocoPhillips Company
26.87%-2.34%-12.02%1.98%71.69%86.60%-36.04%6.63%15.63%11.95%
EDIT
Editas Medicine, Inc.
21.95%61.42%-87.46%14.21%-66.59%-62.13%136.78%30.15%-25.97%89.34%

Correlation

The correlation between COP and EDIT is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Feb 3, 2016

0.12

The correlation between COP and EDIT shifts across timeframes, from -0.11 (1 year) to 0.12 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

COP:

$143.30B

EDIT:

$244.70M

EPS

COP:

$5.90

EDIT:

-$1.21

PS Ratio

COP:

2.49

EDIT:

6.29

PB Ratio

COP:

2.22

EDIT:

55.51

Total Revenue (TTM)

COP:

$58.31B

EDIT:

$35.86M

Gross Profit (TTM)

COP:

$17.02B

EDIT:

$35.86M

EBITDA (TTM)

COP:

$22.44B

EDIT:

-$76.66M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COP vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COP
COP Risk / Return Rank: 7070
Overall Rank
COP Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
COP Sortino Ratio Rank: 6666
Sortino Ratio Rank
COP Omega Ratio Rank: 6363
Omega Ratio Rank
COP Calmar Ratio Rank: 7575
Calmar Ratio Rank
COP Martin Ratio Rank: 7474
Martin Ratio Rank

EDIT
EDIT Risk / Return Rank: 5151
Overall Rank
EDIT Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
EDIT Sortino Ratio Rank: 5656
Sortino Ratio Rank
EDIT Omega Ratio Rank: 5353
Omega Ratio Rank
EDIT Calmar Ratio Rank: 4949
Calmar Ratio Rank
EDIT Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COP vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ConocoPhillips Company (COP) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


COPEDITDifference
Sharpe ratioReturn per unit of total volatility

+0.79

Sortino ratioReturn per unit of downside risk

+0.45

Omega ratioGain probability vs. loss probability

1.17

1.11

+0.05

Calmar ratioReturn relative to maximum drawdown

1.86

0.25

+1.62

Martin ratioReturn relative to average drawdown

4.08

0.43

+3.64

COP vs. EDIT - Sharpe Ratio Comparison

The current COP Sharpe Ratio is 0.95, which is higher than the EDIT Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of COP and EDIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

COP vs. EDIT - Drawdown Comparison

The maximum COP drawdown since its inception was -84.55%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for COP and EDIT.


Loading charts...

Drawdown Indicators


COPEDITDifference

Max Drawdown

Largest peak-to-trough decline

-84.55%

-98.92%

+14.37%

Max Drawdown (1Y)

Largest decline over 1 year

-14.90%

-59.88%

+44.98%

Max Drawdown (3Y)

Largest decline over 3 years

-36.19%

-91.18%

+54.99%

Max Drawdown (5Y)

Largest decline over 5 years

-36.19%

-98.66%

+62.47%

Max Drawdown (10Y)

Largest decline over 10 years

-70.66%

-98.92%

+28.26%

Current Drawdown

Current decline from peak

-11.92%

-97.24%

+85.32%

Average Drawdown

Average peak-to-trough decline

-25.49%

-62.63%

+37.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.80%

34.03%

-27.23%

Volatility

COP vs. EDIT - Volatility Comparison

The current volatility for ConocoPhillips Company (COP) is 8.72%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that COP experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


COPEDITDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.72%

32.34%

-23.62%

Volatility (6M)

Calculated over the trailing 6-month period

23.05%

61.63%

-38.58%

Volatility (1Y)

Calculated over the trailing 1-year period

29.33%

94.75%

-65.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.80%

94.12%

-61.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.64%

83.80%

-46.16%

Dividends

COP vs. EDIT - Dividend Comparison

COP's dividend yield for the trailing twelve months is around 2.82%, while EDIT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
COP
ConocoPhillips Company
2.82%3.40%3.35%3.37%4.23%2.70%4.23%2.05%1.86%1.93%1.99%6.30%
EDIT
Editas Medicine, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

COP vs. EDIT - Financials Comparison

This section allows you to compare key financial metrics between ConocoPhillips Company and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
16.05B
0
(COP) Total Revenue
(EDIT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


COP and EDIT have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EDIT has higher volatility (32.34%) compared to COP (8.72%). In terms of maximum drawdown, COP dropped -84.55% vs EDIT's -98.92%.

COP currently has the higher Sharpe Ratio (0.95 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for COP and EDIT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer